Publinova logo
product

Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies


Thema's



Publicatiedatum

Type

Document

Gebruiksrecht
copyright.yescopyright.yescopyright.yescopyright.yes
Toegangsrecht

OpenAccess

DOI

Niet bekend